Aedicef-CV is an antibiotic which is prescribed for variety of bacterial infections including pneumonia, strep throat, and bronchitis. It has been formulated using cefixime & potassium clavulanate as active compounds. This medicine works by stopping synthesis of bacterial cell wall by binding to penicillin binding proteins. Aedicef-CV inhibits final transpeptidation step of peptidoglycan synthesis which results in death of bacteria. It is known to have bioavailability of 30 to 50% with good protein binding ability of up to 60%. This drug belongs to beta-lactamase inhibitor class and gets excreted from kidney with elimination half life of 3 to 4 hours.